1.Liver disease and anti-HCV antibody.
Sung Man CHOI ; Joung A KANG ; Kyung Eun SONG ; Jang Soo SUH ; Won Kil LEE ; Jay Sik KIM
Korean Journal of Clinical Pathology 1991;11(3):643-654
No abstract available.
Liver Diseases*
;
Liver*
2.Immunophenotyping and DNA analysis of lymphoid leukemic cells by FACScan system.
Young Ho HAHM ; Joung A KANG ; Kyung Eun SONG ; Jang Soo SUH ; Won Kil LEE ; Jay Sik KIM ; Kun Soo LEE ; Ja Hun KOO
Korean Journal of Clinical Pathology 1992;12(4):445-455
No abstract available.
DNA*
;
Immunophenotyping*
3.Comparison of Antimicrobial Susceptibility of Nosocomial and Community-Acquired Pathogens in Children of Medium-Sized Hospital.
Kil Soo JOUNG ; Jae Kook CHA ; Kon Hee LEE ; Hye Sun YOON ; Wonkeun SONG
Journal of the Korean Pediatric Society 1997;40(11):1537-1543
PURPOSE: We evaluated the identification and antimicrobial susceptibility patterns of nosocomial and community-acquired pathogens in children of the medium-sized hospital. METHODS: The 357 bacterial strains isolated from Pediatric department of Dongsan Sacred Heart Hospital were examined the species identification and antimicrobial susceptibility test during the period of March to October 1996. RESULTS: Fifty three strains (15%) of 357 strains were nosocomial pathogens. A half of Enterococcus faecium is nosocomial pathogens. As a rule, Antimicrobial resistance of nosocomial pathogens were higher than those of community-acquired pathogens. Enterococcus sp. isolated from nosocomial infection were significantly less susceptible than those from community-acquired infection to imipemem (P<0.05). Escherichia coli isolated from nosocomial infection were significantly less susceptible than those from community-acquired infection to amoxicillin/clavulanate, cefuroxime, cefoxitin, ceftazidime, and aztreonam (P<0.05). Klebsiella pneumoniae isolated from nosocomial infection were significantly less susceptible than those from community-acquired infection to cephalothin, cefuroxime, cefotaxime, aztreonam, tobramycin, gentamicin, and co-trimoxazole (P<0.05). CONCLUSIONS: In medium-sized hospital, the rate of antimicrobial resistance to nosocomial pathogens was higher than community-acquired pathogens. The regular reports of the susceptibility patterns of nosocomial and community-acquired pathogens would be useful to improve the effects of empirical antimicrobial therapy.
Aztreonam
;
Cefotaxime
;
Cefoxitin
;
Ceftazidime
;
Cefuroxime
;
Cephalothin
;
Child*
;
Community-Acquired Infections
;
Cross Infection
;
Enterococcus
;
Enterococcus faecium
;
Escherichia coli
;
Gentamicins
;
Heart
;
Humans
;
Klebsiella pneumoniae
;
Tobramycin
;
Trimethoprim, Sulfamethoxazole Drug Combination
4.A Case of Chronic Active Epstein-Barr Virus Infection with Autoimmnune Hepatitis and a Coronary Aneurysm.
Mi Jin KIM ; Ji Joung LEE ; Kyoung Soo PARK ; Sun Young KIM ; Hong Ryang KIL
Korean Journal of Hematology 2006;41(4):311-316
Infectious mononucleosis caused by primary infection of Epstein-Barr virus (EBV) is a self-limiting lymphoproliferative disease, and shows concomitant clinical features such as pyrexia, anorexia, sore throat, cervical lymphadenopathy, liver dysfunction and hepatosplenomegaly. In rare cases, EBV establishes a latent infection in B lymphocytes and runs a chronic course and shows infectious mononucleosis-like symptoms repeatedly. This syndrome, named chronic active EBV infection, may trigger an autoimmune disease that mainly affectes the liver and red blood cells, and carries a very poor prognosis. The cardiovascular complications of chronic active EBV infection are very rare and may be associated with coronary arterial disease. This case describes a 5-year-old boy, who developed chronic active EBV infection and was diagnosed as having autoimmune hepatitis with a coronary aneurysm.
Anorexia
;
Autoimmune Diseases
;
B-Lymphocytes
;
Child, Preschool
;
Coronary Aneurysm*
;
Epstein-Barr Virus Infections
;
Erythrocytes
;
Fever
;
Hepatitis*
;
Hepatitis, Autoimmune
;
Herpesvirus 4, Human*
;
Humans
;
Infectious Mononucleosis
;
Liver
;
Liver Diseases
;
Lymphatic Diseases
;
Male
;
Pharyngitis
;
Prognosis
5.Comparision of doxorubicin-induced cardiotoxicity in the ICR mice of different sources.
Sou Hyun KIM ; Keuk Jun KIM ; Joung Hee KIM ; Jae Hwan KWAK ; HyunKeun SONG ; Joon Young CHO ; Dae Youn HWANG ; Kil Soo KIM ; Young Suk JUNG
Laboratory Animal Research 2017;33(2):165-170
Doxorubicin is a widely used chemotherapeutic agents and is now part of standard therapeutic regimens for a variety of cancers (eg, hematopoietic malignancies and advanced solid tumors of the breast, ovary, thyroid, and bone). However, a potentially lethal and dose-dependent cardiotoxicity that appears within a short time after treatment limits the usage of doxorubicin in cancer patients. Although the mechanism of doxorubicin-induced cardiotoxicity is not completely understood, it is thought that free radical-induced oxidative stress and excessive production of reactive oxygen species are primary drivers of its toxicity. In this study, we compared the doxorubicin-induced cardiotoxicity of ICR mice obtained from three different sources and evaluated the utility of Korl:ICR stock established by the Korean FDA. Because doxorubicin-induced cardiotoxicity is thought to involve the excessive generation of ROS followed by oxidative stress, we determined the representative tissue index of oxidation, lipid peroxidation, and antioxidant, glutathione (GSH), as well as the parameters of heart injury. Doxorubicin treatment successfully induced cardiotoxicity as evidenced by histological examination and serum parameters (eg, levels of LDH and CK activities) in ICR mice. It was accompanied by increased lipid peroxidation and a decrease in both cysteine and GSH, further supporting previous reports that oxidative stress is a potential mechanism of doxorubicin-induced cardiotoxicity. Of interest, we did not observe a significant difference in doxorubicin-induced cardiotoxicity among mice of different origins. Collectively, our results suggest that Korl:ICR strain may be useful in the research of doxorubicin-induced cardiotoxicity.
Animals
;
Breast
;
Cardiotoxicity*
;
Cysteine
;
Doxorubicin
;
Female
;
Glutathione
;
Heart Injuries
;
Hematologic Neoplasms
;
Humans
;
Lipid Peroxidation
;
Mice
;
Mice, Inbred ICR*
;
Ovary
;
Oxidative Stress
;
Reactive Oxygen Species
;
Thyroid Gland
6.Comparative study of fatty liver induced by methionine and choline-deficiency in C57BL/6N mice originating from three different sources.
Sou Hyun KIM ; Yong LIM ; Ju Bin PARK ; Jae Hwan KWAK ; Keuk Jun KIM ; Joung Hee KIM ; HyunKeun SONG ; Joon Young CHO ; Dae Youn HWANG ; Kil Soo KIM ; Young Suk JUNG
Laboratory Animal Research 2017;33(2):157-164
Non-alcoholic fatty liver disease (NAFLD) is believed to be the most prevalent liver disease worldwide and a major cause of chronic liver injury. It is characterized by lipid accumulation in the absence of significant alcohol consumption and frequently progresses to steatohepatitis, liver fibrosis, and hepatocellular carcinoma. Although many studies have been conducted to better understand NAFLD since it was first recognized, there are still many gaps in knowledge of etiology, prognosis, prevention and treatment. Methionine-choline deficient (MCD) diet, a well-established experimental model of NAFLD in rodents, rapidly and efficiently produces the clinical pathologies including macrovesicular steatosis and leads to disease progression. In this study, we measured the response to MCD diet in C57BL/6N mice obtained from three different sources; Korea NIFDS, USA, and Japan. We evaluated changes in body weight, food consumption, and relative weights of tissues such as liver, kidney, gonadal white adipose tissue, inguinal white adipose tissue, and brown adipose tissue. These basic parameters of mice with an MCD diet were not significantly different among the sources of mice tested. After 3 weeks on an MCD diet, histopathological analyses showed that the MCD diet induced clear fat vacuoles involving most area of the acinus in the liver of all mice. It was accompanied by increased serum activities of alanine aminotransferase and aspartate aminotransferase, and decreased levels of serum triglyceride and cholesterol. In conclusion, the response of C57BL6N mice originating from different sources to the MCD diet showed no significant differences as measured by physiological, biochemical, and histopathological parameters.
Adipose Tissue, Brown
;
Adipose Tissue, White
;
Alanine Transaminase
;
Alcohol Drinking
;
Animals
;
Aspartate Aminotransferases
;
Body Weight
;
Carcinoma, Hepatocellular
;
Cholesterol
;
Diet
;
Disease Progression
;
Fatty Liver*
;
Gonads
;
Japan
;
Kidney
;
Korea
;
Liver
;
Liver Cirrhosis
;
Liver Diseases
;
Methionine*
;
Mice*
;
Models, Theoretical
;
Non-alcoholic Fatty Liver Disease
;
Pathology
;
Prognosis
;
Rodentia
;
Triglycerides
;
Vacuoles
;
Weights and Measures
7.Erratum: Comparison of doxorubicin-induced cardiotoxicity in the ICR mice of different sources.
Sou Hyun KIM ; Keuk Jun KIM ; Joung Hee KIM ; Jae Hwan KWAK ; HyunKeun SONG ; Joon Young CHO ; Dae Youn HWANG ; Kil Soo KIM ; Young Suk JUNG
Laboratory Animal Research 2017;33(4):319-319
One of the authors' names was misprinted.
8.Erratum: Comparative study of fatty liver induced by methionine and choline-deficiency in C57BL/6N mice originating from three different sources.
Sou Hyun KIM ; Yong LIM ; Ju Bin PARK ; Jae Hwan KWAK ; Keuk Jun KIM ; Joung Hee KIM ; HyunKeun SONG ; Joon Young CHO ; Dae Youn HWANG ; Kil Soo KIM ; Young Suk JUNG
Laboratory Animal Research 2017;33(4):318-318
One of the authors' names was misprinted.
9.The Nationwide Incidence of Retinal Vein Occlusion Following Dialysis due to End-stage Renal Disease in Korea, 2004 through 2013
Tae Hwan MOON ; Joung-Ho HAN ; Minseok KANG ; Ji Soo KIM ; Jin Young KIM ; Ju Byung CHAE ; Soon Kil KWON ; Gilwon KANG ; Dong Yoon KIM
Journal of Korean Medical Science 2021;36(30):e201-
Background:
We investigated the incidence and risk of retinal vein occlusion (RVO) in endstage renal disease (ESRD) patients on dialysis in Korea.
Methods:
In this nationwide cohort study, we used Korean National Health Insurance Service data between 2004 and 2013 for analysis. ESRD patients who started dialysis from 2004 to 2013 and an equal number of controls were selected through propensity score matching. RVO incidence in both cohorts were calculated for 2004–2013 using washout data from 2003. The multivariable Cox proportional hazards model was used to assess the risk of RVO in dialysis cohort. The Kaplan-Meier method was used to generate the cumulative RVO incidence curve.Whether the dialysis modality affects the development of RVO was also evaluated.
Results:
In this study, 74,551 ESRD patients on dialysis and the same number of controls were included. The incidence of RVO was significantly higher in the dialysis cohort than in the control cohort (dialysis = 7.3/1,000 person-years [PY]; control = 1.9/1,000 PY; P < 0.001). The cumulative-incidence of RVO was also significantly higher in the dialysis cohort than in the control cohort (P < 0.001; log-rank test). However, there was no significant difference in the incidence of RVO between the two dialysis methods (P = 0.550; log-rank test).
Conclusion
This study provided epidemiological evidence that receiving dialysis for ESRD could increase the risk of developing RVO. We also found a rapid increase in the incidence of RVO with a longer dialysis period. These results strengthen the relationship between retinal vascular disease and renal function.
10.The Nationwide Incidence of Retinal Vein Occlusion Following Dialysis due to End-stage Renal Disease in Korea, 2004 through 2013
Tae Hwan MOON ; Joung-Ho HAN ; Minseok KANG ; Ji Soo KIM ; Jin Young KIM ; Ju Byung CHAE ; Soon Kil KWON ; Gilwon KANG ; Dong Yoon KIM
Journal of Korean Medical Science 2021;36(30):e201-
Background:
We investigated the incidence and risk of retinal vein occlusion (RVO) in endstage renal disease (ESRD) patients on dialysis in Korea.
Methods:
In this nationwide cohort study, we used Korean National Health Insurance Service data between 2004 and 2013 for analysis. ESRD patients who started dialysis from 2004 to 2013 and an equal number of controls were selected through propensity score matching. RVO incidence in both cohorts were calculated for 2004–2013 using washout data from 2003. The multivariable Cox proportional hazards model was used to assess the risk of RVO in dialysis cohort. The Kaplan-Meier method was used to generate the cumulative RVO incidence curve.Whether the dialysis modality affects the development of RVO was also evaluated.
Results:
In this study, 74,551 ESRD patients on dialysis and the same number of controls were included. The incidence of RVO was significantly higher in the dialysis cohort than in the control cohort (dialysis = 7.3/1,000 person-years [PY]; control = 1.9/1,000 PY; P < 0.001). The cumulative-incidence of RVO was also significantly higher in the dialysis cohort than in the control cohort (P < 0.001; log-rank test). However, there was no significant difference in the incidence of RVO between the two dialysis methods (P = 0.550; log-rank test).
Conclusion
This study provided epidemiological evidence that receiving dialysis for ESRD could increase the risk of developing RVO. We also found a rapid increase in the incidence of RVO with a longer dialysis period. These results strengthen the relationship between retinal vascular disease and renal function.